Connect Biopharma Holdings Limited Ordinary Shares (CNTB) Stock Price

CNTBStock

$2.23+26.70%52W

Market Cap$140.43M

P/E—

PEG Ratio—

Div yield—

Beta-0.20

CNTB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-20.91%

Price vs S&P 500 (4W)11.66%

VGM Score22.95

Book Value / Share (Quarterly)$0.68

P/TBV (Annual)0.83x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.92

Price vs S&P 500 (YTD)-33.74%

Net Profit Margin (TTM)-21243.35%

EPS (TTM)$-1.15

10-Day Avg Trading Volume0.47M

EPS Excl Extra (TTM)$-1.15

EPS (Annual)$-1.00

ROI (Annual)-16.96%

Cash / Share (Quarterly)$0.73

Revenue Growth QoQ (YoY)-99.80%

ROA (Last FY)-15.43%

EBITD / Share (TTM)$-1.17

Operating Margin (TTM)-21763.09%

Cash Flow / Share (Annual)$-0.44

P/B Ratio3.75x

P/B Ratio (Quarterly)3.47x

Net Income / Employee (Annual)$-866,900

EV / Revenue (TTM)488.82x

Net Interest Coverage (TTM)-86.06x

ROA (TTM)-97.07%

EPS Incl Extra (Annual)$-1.00

Current Ratio (Annual)11.46x

Quick Ratio (Quarterly)2.86x

3-Month Avg Trading Volume0.37M

52-Week Price Return26.70%

Revenue / Employee (TTM)$3,600

Tangible BV / Share (Quarterly)$0.68

P/S Ratio (Annual)2498.88x

Asset Turnover (Annual)0.26x

52-Week High$3.82

EPS Excl Extra (Annual)$-1.00

CapEx CAGR (5Y)-50.96%

26-Week Price Return-8.98%

Quick Ratio (Annual)11.20x

13-Week Price Return-6.30%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.23x

Enterprise Value$113.89M

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$1,000

Pretax Margin (Annual)-86379.69%

Cash / Share (Annual)$1.69

3-Month Return Std Dev75.91%

Net Income / Employee (TTM)$-1,009,500

ROE (Last FY)-16.96%

EPS Basic Excl Extra (Annual)$-1.00

Receivables Turnover (TTM)58.25x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.15

ROI (TTM)-122.29%

P/S Ratio (TTM)686.39x

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$1.66

Price vs S&P 500 (52W)8.15%

Year-to-Date Return-20.92%

5-Day Price Return-3.04%

EPS Normalized (Annual)$-1.00

ROA (5Y Avg)-54.44%

Net Profit Margin (Annual)-86687.50%

Month-to-Date Return10.40%

EBITD / Share (Annual)$-1.03

Operating Margin (Annual)-90740.62%

LT Debt / Equity (Annual)0.00x

EPS Basic Excl Extra (TTM)$-1.15

P/TBV (Quarterly)3.48x

P/B Ratio (Annual)0.83x

Pretax Margin (TTM)-21172.96%

Book Value / Share (Annual)$1.67

Price vs S&P 500 (13W)-8.26%

Beta-0.20x

Revenue / Share (TTM)$0.00

ROE (TTM)-122.29%

52-Week Low$1.23

vGradeF

gGradeF

mGradeC

vgmGradeD

CNTB Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 12, 2026	-$0.31	-$0.27	+12.34%(+$0.04)
Q4 2025	Mar 31, 2026	-$0.30	-$0.27	+10.00%(+$0.03)
Q3 2025	Nov 12, 2025	-$0.23	-$0.31	-31.91%(-$0.08)

CNTB Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.27

4.23

4.29

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
CNTBConnect Biopharma Holdings Limited Ordinary Shares	F	F	C	$2.23
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Connect Biopharma Holdings Limited Ordinary Shares

Connect Biopharma is a clinical-stage biopharmaceutical company developing next-generation immune modulators to treat autoimmune diseases and inflammatory conditions. The company leverages expertise in T cell modulation to build a pipeline of small molecule and antibody candidates targeting key inflammation pathways. Its lead programs include CBP-201, CBP-307, and CBP-174.